| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABBV | Common Stock, $0.01 par value | Options Exercise | $168,300 | +1,800 | +26% | $93.50 | 8,783 | 16 Dec 2024 | Direct | |
| transaction | ABBV | Common Stock, $0.01 par value | Sale | $310,032 | -1,800 | -20% | $172.24 | 6,983 | 16 Dec 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABBV | Option (Right to buy) | Options Exercise | $168,300 | -1,800 | -13% | $93.50 | 12,111 | 16 Dec 2024 | Common Stock | 1,800 | $93.50 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |